基于机器学习的简化Martin-Hopkins LDL-C公式的开发与验证
结果显示LDL-C-MH-MARS的偏差、RMSE和分类一致性均与Martin-Hopkins相当或更优,且简化为单一公式。
要点
- LDL-C-MH-MARS公式在大型队列中与Martin-Hopkins公式准确性相当,且简化为单一公式。
- 在外部验证数据集中,LDL-C-MH-MARS与Martin-Hopkins公式同样表现出最高准确性。
- 对于甘油三酯200-399 mg/dL且LDL-C<70 mg/dL的患者,LDL-C-MH-MARS低估比例(16%)低于其他公式。
核心结论
- 新型机器学习LDL-C公式(LDL-C-MH-MARS)提供了与原始Martin-Hopkins方法相当的结果,同时简化为单一公式便于实施。
研究设计与样本
- 外部验证使用Mayo Clinic参考实验室数据集(宽LDL-C浓度范围)和FOURIER试验数据集(接受evolocumab治疗的低LDL-C浓度患者观察值)。
主要发现
- LDL-C-MH-MARS的中位(IQR)偏差为-0.1(-2.1至1.8)mg/dL,与LDL-C-MH相当。
- LDL-C-MH-MARS与LDL-C-MH的中位(IQR)差值为-0.5(-1.2至0)mg/dL。
- RMSE最小为LDL-C-MH-MARS(4.7 mg/dL)和LDL-C-MH(4.9 mg/dL),其次为LDL-C-S(5.8 mg/dL)、LDL-C-MS(6.0 mg/dL)、LDL-C-F(7.2 mg/dL)。
- 按临床类别正确分类的比例:LDL-C-MH-MARS(89.7%)与LDL-C-MH(89.6%)几乎相同,LDL-C-S(86.3%)、LDL-C-MS(84.7%)、LDL-C-F(83.1%)较低。
- 在甘油三酯200-399 mg/dL且LDL-C<70 mg/dL的患者中,LDL-C-MH-MARS、LDL-C-MH、LDL-C-MS、LDL-C-S、LDL-C-F分别低估16%、17%、28%、39%、60%。
临床怎么用
- LDL-C-MH-MARS可作为一种简化的单一公式替代Martin-Hopkins公式用于估算LDL-C,便于临床实施和推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although the Martin-Hopkins equation is widely validated and used to estimate low-density lipoprotein cholesterol (LDL-C) for clinical care, a simplified equation could streamline implementation and enable broader adoption. OBJECTIVE: To develop a simplified machine learning-based alternative to the Martin-Hopkins equation using multivariate adaptive regression splines (LDL-C-MH-MARS) and compare its performance with the Friedewald (LDL-C-F), Sampson-National Institutes of Health (LDL-C-S), Modified Sampson (LDL-C-MS), and Martin-Hopkins (LDL-C-MH) equations. DESIGN, SETTING, AND PARTICIPANTS: The Very Large Database of Lipids is a cross-sectional database of clinical lipid measurements from a population-representative convenience sample of adult and pediatric patients. Lipid measurements were performed by Vertical Auto Profile ultracentrifugation between October 1, 2015, and June 30, 2019. The study included patients with complete lipid panel data who were randomly assigned to a training set and a test set. External validation against preparative ultracentrifugation-based LDL-C measurements was performed in reference laboratory datasets from the Mayo Clinic (broad LDL-C concentrations) and the Further Cardiovascular Outcomes Research With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Subjects with Elevated Risk (FOURIER) trial (observations from patients with low LDL-C concentrations while taking evolocumab). Study data were analyzed from January to October 2025. EXPOSURES: LDL-C-F, LDL-C-S, LDL-C-MS, LDL-C-MH, and LDL-C-MH-MARS equations. MAIN OUTCOMES AND MEASURES: Accuracy of estimated vs ultracentrifugation-measured LDL-C concentration based on bias, root mean square error (RMSE), and concordance by guideline-based categories. RESULTS: The study included 4 939 528 patients (mean [SD] age, 56 [16] years; 2 635 486 female [53%]) with complete lipid panel data who were randomly assigned to a training set (n = 3 292 889) and a test set (n = 1 646 639). LDL-C-MH-MARS equation demonstrated a very low median (IQR) bias of -0.1 (-2.1 to 1.8) mg/dL (to convert to millimoles per liter, multiply by 0.0259), comparable with LDL-C-MH. The median (IQR) difference between the MARS and original Martin-Hopkins equations (ie, LDL-C-MH-MARS - LDL-C-MH) was -0.5 (-1.2 to 0) mg/dL, further suggesting comparability between the 2 methods. The RMSE was smallest for LDL-C-MH-MARS (4.7 mg/dL) and LDL-C-MH (4.9 mg/dL), followed by LDL-C-S (5.8 mg/dL), LDL-C-MS (6.0 mg/dL), and LDL-C-F (7.2 mg/dL). The proportion of patients correctly classified according to clinical categories was nearly identical for LDL-C-MH-MARS (89.7%) and LDL-C-MH (89.6%) but lower for LDL-C-S (86.3%), LDL-C-MS (84.7%), and LDL-C-F (83.1%). The LDL-C-MH-MARS, LDL-C-MH, LDL-C-MS, LDL-C-S, and LDL-C-F equations underestimated LDL-C concentration in 16%, 17%, 28%, 39%, and 60%, respectively, when classifying LDL-C less than 70 mg/dL in patients with triglyceride concentrations of 200 to 399 mg/dL (to convert to millimoles per liter, multiply by 0.0113). The patterns of results were similar in external validation datasets, with the LDL-C-MH-MARS and LDL-C-MH equations demonstrating the highest accuracy. CONCLUSIONS AND RELEVANCE: Study results suggest that the new machine learning-based LDL-C equation provided results comparable with those of the original Martin-Hopkins method while simplifying implementation to a single equation.
引用
- Park J, Fan L, Marzinke MA, et al. Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning. JAMA Cardiol. 2026. PMID: 42455545. doi:10.1001/jamacardio.2026.2314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。